BPG is committed to discovery and dissemination of knowledge
Prospective Study
©The Author(s) 2026.
World J Hepatol. Jan 27, 2026; 18(1): 113429
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113429
Figure 1
Figure 1 Flowchart of patient selection and enrollment with histopathologically confirmed hepatic malignancies undergoing radiofrequency ablation. HCC: Hepatocellular carcinoma; RFA: Radiofrequency ablation; TACE: Transarterial chemoembolization.


Write to the Help Desk